Felbamate, a novel antiepileptic drug, reverses N-methyl-D-aspartate/glycine-stimulated increases in intracellular Ca2+ concentration
- 28 April 1995
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 289 (2) , 229-233
- https://doi.org/10.1016/0922-4106(95)90099-3
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Selective antagonism of the anticonvulsant effects of felbamate by glycineEuropean Journal of Pharmacology, 1994
- Mechanism of action of the anticonvulsant felbamate: Opposing effects on N‐methyl‐D‐aspartate and γ‐aminobutyric acidA receptorsAnnals of Neurology, 1994
- Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia‐ischemiaNeurology, 1993
- Glycine reversal of felbamate hypoxic protectionNeuroReport, 1993
- A Neuropharmacological Evaluation of Felbamate as a Novel AnticonvulsantEpilepsia, 1992
- Protective effects of felbamate against hypoxia in the rat hippocampal slice.Stroke, 1992
- Felbamate reduces hypoxic-ischemic brain damage in vivoEuropean Journal of Pharmacology, 1992
- Glycine potentiates the NMDA response in cultured mouse brain neuronsNature, 1987
- Comparative Anticonvulsant Activity and Neurotoxicity of Felbamate and Four Prototype Antiepileptic Drugs in Mice and RatsEpilepsia, 1986
- Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengthsCell Calcium, 1985